Amyloidosis E85- >

Type 2 Excludes
Type 2 Excludes Help
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (E85) and the excluded code together.
  • Alzheimer's disease (
    ICD-10-CM Diagnosis Code G30.0

    Alzheimer's disease with early onset

      2016 2017 2018 2019 2020 Billable/Specific Code
    G30.0-
    )
Clinical Information
  • A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.
  • A group of diseases in which protein builds up in certain organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis may be either primary (with no known cause), secondary (caused by another disease, including some types of cancer, such as multiple myeloma), or hereditary (passed down from parents to children). Many organs are affected by amyloidosis. The organs affected may depend on whether the amyloidosis is the primary, secondary, or hereditary form.
  • A group of diseases in which protein is deposited in specific organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis may be either primary (plasma cell neoplasm) or secondary (caused by a long standing infection or another disease or some types of cancer). Generally, primary amyloidosis affects the nerves, skin, tongue, joints, heart, and liver; secondary amyloidosis often affects the spleen, kidneys, liver, and adrenal glands.
  • A group of diseases in which protein is deposited in specific organs or throughout the body.
  • A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of amyloid. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
  • Amyloidosis occurs when abnormal proteins build up and form deposits. The deposits can collect in organs such as the kidney and heart. This can cause the organs to become stiff and unable to work the way they should. There are three main types of amyloidosis:
    • primary - with no known cause
    • secondary - caused by another disease, including some types of cancer
    • familial - passed down through genes
    treatment depends on the type of amyloidosis you have.
  • Any disease manifested by the pathogenic accumulation of amyloid in organs and tissues.
Codes
  • E85 Amyloidosis
    • E85.0 Non-neuropathic heredofamilial amyloidosis
    • E85.1 Neuropathic heredofamilial amyloidosis
    • E85.2 Heredofamilial amyloidosis, unspecified
    • E85.3 Secondary systemic amyloidosis
    • E85.4 Organ-limited amyloidosis
    • E85.8 Other amyloidosis
      • E85.81 Light chain (AL) amyloidosis
      • E85.82 Wild-type transthyretin-related (ATTR) amyloidosis
      • E85.89 Other amyloidosis
    • E85.9 Amyloidosis, unspecified